BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 19533653)

  • 1. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
    Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
    Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
    J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
    Doucet M; Russell AP; Léger B; Debigaré R; Joanisse DR; Caron MA; LeBlanc P; Maltais F
    Am J Respir Crit Care Med; 2007 Aug; 176(3):261-9. PubMed ID: 17478621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
    Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
    Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
    Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
    Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
    Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass.
    Consitt LA; Saneda A; Saxena G; List EO; Kopchick JJ
    Skelet Muscle; 2017 Sep; 7(1):17. PubMed ID: 28870245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of genes encoding eIF4E binding proteins-1 and -2 does not alter basal or sepsis-induced changes in skeletal muscle protein synthesis in male or female mice.
    Steiner JL; Pruznak AM; Deiter G; Navaratnarajah M; Kutzler L; Kimball SR; Lang CH
    PLoS One; 2014; 9(6):e99582. PubMed ID: 24945486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1.
    Léger B; Vergani L; Sorarù G; Hespel P; Derave W; Gobelet C; D'Ascenzio C; Angelini C; Russell AP
    FASEB J; 2006 Mar; 20(3):583-5. PubMed ID: 16507768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
    Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of divergent exercise contraction mode and whey protein supplementation on atrogin-1, MuRF1, and FOXO1/3A in human skeletal muscle.
    Stefanetti RJ; Lamon S; Rahbek SK; Farup J; Zacharewicz E; Wallace MA; Vendelbo MH; Russell AP; Vissing K
    J Appl Physiol (1985); 2014 Jun; 116(11):1491-502. PubMed ID: 24458747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
    Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
    Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
    Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes.
    Wang DT; Yin Y; Yang YJ; Lv PJ; Shi Y; Lu L; Wei LB
    Int Immunopharmacol; 2014 Apr; 19(2):206-13. PubMed ID: 24534773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin E3 ligase Atrogin-1 protein is regulated via the rapamycin-sensitive mTOR-S6K1 signaling pathway in C2C12 muscle cells.
    Nishimura Y; Chunthorng-Orn J; Lord S; Musa I; Dawson P; Holm L; Lai YC
    Am J Physiol Cell Physiol; 2022 Jul; 323(1):C215-C225. PubMed ID: 35704697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Des-acyl ghrelin exhibits pro-anabolic and anti-catabolic effects on C2C12 myotubes exposed to cytokines and reduces burn-induced muscle proteolysis in rats.
    Sheriff S; Kadeer N; Joshi R; Friend LA; James JH; Balasubramaniam A
    Mol Cell Endocrinol; 2012 Apr; 351(2):286-95. PubMed ID: 22266196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of short-term cold exposure on skeletal muscle protein breakdown in rats.
    Manfredi LH; Zanon NM; Garófalo MA; Navegantes LC; Kettelhut IC
    J Appl Physiol (1985); 2013 Nov; 115(10):1496-505. PubMed ID: 23908317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.
    Goodman CA; McNally RM; Hoffmann FM; Hornberger TA
    Mol Endocrinol; 2013 Nov; 27(11):1946-57. PubMed ID: 24002653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.